Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
The Lancet (2016) Vol. 387, Iss. 10035, pp. 2302-2311
Closed Access | Times Cited: 445

Showing 1-25 of 445 citing articles:

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, et al.
European Heart Journal (2020) Vol. 42, Iss. 5, pp. 373-498
Open Access | Times Cited: 8255
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, et al.
European Heart Journal (2016) Vol. 37, Iss. 38, pp. 2893-2962
Open Access | Times Cited: 6118
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, et al.
EP Europace (2016) Vol. 18, Iss. 11, pp. 1609-1678
Open Access | Times Cited: 5826
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli, Héctor Bueno, Robert A. Byrne, et al.
European Heart Journal (2017) Vol. 39, Iss. 3, pp. 213-260
Open Access | Times Cited: 2615
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel, Peter Verhamme, Tatjana Potpara, et al.
European Heart Journal (2018) Vol. 39, Iss. 16, pp. 1330-1393
Open Access | Times Cited: 1903
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, et al.
European Journal of Cardio-Thoracic Surgery (2016) Vol. 50, Iss. 5, pp. e1-e88
Open Access | Times Cited: 1378
Stroke
Graeme J. Hankey
The Lancet (2016) Vol. 389, Iss. 10069, pp. 641-654
Closed Access | Times Cited: 1051
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
Francesco Costa, David van Klaveren, Stefan James, et al.
The Lancet (2017) Vol. 389, Iss. 10073, pp. 1025-1034
Closed Access | Times Cited: 1008
Antithrombotic Therapy for Atrial Fibrillation
Gregory Y.H. Lip, Amitava Banerjee, Giuseppe Boriani, et al.
CHEST Journal (2018) Vol. 154, Iss. 5, pp. 1121-1201
Open Access | Times Cited: 825
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Kai C. Wollert, Tibor Kempf, Lars Wallentin
Clinical Chemistry (2016) Vol. 63, Iss. 1, pp. 140-151
Open Access | Times Cited: 453
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli, Héctor Bueno, Robert A. Byrne, et al.
European Journal of Cardio-Thoracic Surgery (2017) Vol. 53, Iss. 1, pp. 34-78
Open Access | Times Cited: 382
Stroke prevention in atrial fibrillation: Past, present and future
Gregory Y.H. Lip, Ben Freedman, Raffaele De Caterina, et al.
Thrombosis and Haemostasis (2017) Vol. 117, Iss. 07, pp. 1230-1239
Closed Access | Times Cited: 367
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018
David Brieger, John Amerena, John Attia, et al.
Heart Lung and Circulation (2018) Vol. 27, Iss. 10, pp. 1209-1266
Open Access | Times Cited: 274
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the …
Gregory Y H Lip, Jean-Phillippe Collet, Michael Haude, et al.
EP Europace (2018) Vol. 21, Iss. 2, pp. 192-193
Open Access | Times Cited: 236
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary
Jan Steffel, Peter Verhamme, Tatjana Potpara, et al.
EP Europace (2018) Vol. 20, Iss. 8, pp. 1231-1242
Open Access | Times Cited: 230
Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review
Ethan D. Borre, Adam P. Goode, Giselle Raitz, et al.
Thrombosis and Haemostasis (2018) Vol. 118, Iss. 12, pp. 2171-2187
Open Access | Times Cited: 202
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
Carlo Patrono, João Morais, Colin Baigent, et al.
Journal of the American College of Cardiology (2017) Vol. 70, Iss. 14, pp. 1760-1776
Open Access | Times Cited: 177
2020 Clinical guidelines for Atrial fibrillation and atrial flutter
M. S. Arakelyan, L.A. Bockeriа, Elena Vasilieva, et al.
Russian Journal of Cardiology (2021) Vol. 26, Iss. 7, pp. 4594-4594
Open Access | Times Cited: 162
VCAM-1 as a predictor biomarker in cardiovascular disease
Mayarling Francisca Troncoso, Jafet Ortiz‐Quintero, Valeria Garrido‐Moreno, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1867, Iss. 9, pp. 166170-166170
Closed Access | Times Cited: 141
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono K, Yu‐ki Iwasaki, Masaharu Akao, et al.
Circulation Journal (2022) Vol. 86, Iss. 11, pp. 1790-1924
Open Access | Times Cited: 83
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation
Florian A. Wenzl, Simon Kraler, Gareth Ambler, et al.
The Lancet (2022) Vol. 400, Iss. 10354, pp. 744-756
Open Access | Times Cited: 82
Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper
Diana A. Gorog, Ying X. Gue, Tze‐Fan Chao, et al.
Thrombosis and Haemostasis (2022) Vol. 122, Iss. 10, pp. 1625-1652
Open Access | Times Cited: 79
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
Chern‐En Chiang, Ken Okumura, Shu Zhang, et al.
Journal of Arrhythmia (2017) Vol. 33, Iss. 4, pp. 345-367
Open Access | Times Cited: 169
The future of atrial fibrillation management: integrated care and stratified therapy
Paulus Kirchhof
The Lancet (2017) Vol. 390, Iss. 10105, pp. 1873-1887
Open Access | Times Cited: 156
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI
Davide Capodanno, Kurt Huber, Roxana Mehran, et al.
Journal of the American College of Cardiology (2019) Vol. 74, Iss. 1, pp. 83-99
Closed Access | Times Cited: 143
Page 1 - Next Page

Scroll to top